Monika Szczepanowski

Author

Also Known As

Akihiro Suzuki, Dido Lenze, Fred Sweep, Gunther Glehr, Hana Susak, M Szczepanowski, M. Szczepanowski, Matthias Schlesner, Monika Szczepanowski, Peter Möller

148

Publications

19.4K

Citations

H-Index

Concepts

All Affiliations

University of Lübeck Christian-Albrechts-Universität zu Kiel University Hospital Schleswig-Holstein Leipzig University Charité - Universitätsmedizin Berlin

About

Monika Szczepanowski is an author at University of Lübeck specializing in medicine, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.2K
2	Cell Biology	6	6	258
3	Health Sciences	2	2	94
4	Natural Sciences	1	1	32
5	Cellular Physiology	1	1	32

Monika Szczepanowski

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling Michael Hummel, Stefan Bentink, Hilmar Berger, New England Journal of Medicine	2006	1K
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Alessandro Pastore, Vindi Jurinović, Robert Kridel, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyFollicular Lymphoma	2015	608
Comprehensive molecular characterization of mitochondrial genomes in human cancers Yuan Yuan, Young Seok Ju, Young-Wook Kim, Nature Genetics	2020	489
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults Itziar Salaverría, Claudia Philipp, Ilske Oschlies, Blood	2011	287
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao, Gurnit Atwal, Paz Polak, Nature Communications	2020	230
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy Vindi Jurinović, Robert Kridel, Annette M. Staiger, Blood	2016	226
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma Itziar Salaverría, Idoia Martín‐Guerrero, Rabea Wagener, Blood	2014	225
Clinical Impact of the Cell-of-Origin Classification and the <i>MYC</i> / <i>BCL2</i> Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group Annette M. Staiger, Marita Ziepert, Heike Horn, Journal of Clinical Oncology	2017	214
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL German Ott, Marita Ziepert, Wolfram Klapper, Blood	2010	200

Page 1